These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 27746343

  • 1. Revealing the role of the endocannabinoid system modulators, SR141716A, URB597 and VDM-11, in sleep homeostasis.
    Murillo-Rodríguez E, Machado S, Rocha NB, Budde H, Yuan TF, Arias-Carrión O.
    Neuroscience; 2016 Dec 17; 339():433-449. PubMed ID: 27746343
    [Abstract] [Full Text] [Related]

  • 2. Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat.
    Murillo-Rodríguez E, Vázquez E, Millán-Aldaco D, Palomero-Rivero M, Drucker-Colin R.
    Eur J Pharmacol; 2007 May 07; 562(1-2):82-91. PubMed ID: 17336288
    [Abstract] [Full Text] [Related]

  • 3. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release.
    Seillier A, Giuffrida A.
    Neuropharmacology; 2018 Mar 01; 130():1-9. PubMed ID: 29169961
    [Abstract] [Full Text] [Related]

  • 4. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
    Forget B, Guranda M, Gamaleddin I, Goldberg SR, Le Foll B.
    Psychopharmacology (Berl); 2016 May 01; 233(10):1823-8. PubMed ID: 26864774
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of endocannabinoid metabolism attenuates enhanced hippocampal neuronal activity induced by kainic acid.
    Coomber B, O'Donoghue MF, Mason R.
    Synapse; 2008 Oct 01; 62(10):746-55. PubMed ID: 18651640
    [Abstract] [Full Text] [Related]

  • 6. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
    Haller VL, Stevens DL, Welch SP.
    Eur J Pharmacol; 2008 Dec 14; 600(1-3):50-8. PubMed ID: 18762181
    [Abstract] [Full Text] [Related]

  • 7. Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat.
    Cross-Mellor SK, Ossenkopp KP, Piomelli D, Parker LA.
    Psychopharmacology (Berl); 2007 Feb 14; 190(2):135-43. PubMed ID: 17111174
    [Abstract] [Full Text] [Related]

  • 8. Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats.
    Trezza V, Damsteegt R, Manduca A, Petrosino S, Van Kerkhof LW, Pasterkamp RJ, Zhou Y, Campolongo P, Cuomo V, Di Marzo V, Vanderschuren LJ.
    J Neurosci; 2012 Oct 24; 32(43):14899-908. PubMed ID: 23100412
    [Abstract] [Full Text] [Related]

  • 9. Effects of endocannabinoid neurotransmission modulators on brain stimulation reward.
    Vlachou S, Nomikos GG, Panagis G.
    Psychopharmacology (Berl); 2006 Oct 24; 188(3):293-305. PubMed ID: 16953388
    [Abstract] [Full Text] [Related]

  • 10. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
    Herradón E, Martín MI, López-Miranda V.
    Br J Pharmacol; 2007 Nov 24; 152(5):699-708. PubMed ID: 17704831
    [Abstract] [Full Text] [Related]

  • 11. The administration of endocannabinoid uptake inhibitors OMDM-2 or VDM-11 promotes sleep and decreases extracellular levels of dopamine in rats.
    Murillo-Rodríguez E, Palomero-Rivero M, Millán-Aldaco D, Di Marzo V.
    Physiol Behav; 2013 Jan 17; 109():88-95. PubMed ID: 23238438
    [Abstract] [Full Text] [Related]

  • 12. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
    Fidelman S, Mizrachi Zer-Aviv T, Lange R, Hillard CJ, Akirav I.
    Eur Neuropsychopharmacol; 2018 May 17; 28(5):630-642. PubMed ID: 29519609
    [Abstract] [Full Text] [Related]

  • 13. The anandamide membrane transporter inhibitor, VDM-11, modulates sleep and c-Fos expression in the rat brain.
    Murillo-Rodríguez E, Millán-Aldaco D, Di Marzo V, Drucker-Colín R.
    Neuroscience; 2008 Nov 11; 157(1):1-11. PubMed ID: 18822353
    [Abstract] [Full Text] [Related]

  • 14. Endocannabinoid modulation of male rat sexual behavior.
    Gorzalka BB, Morrish AC, Hill MN.
    Psychopharmacology (Berl); 2008 Jul 11; 198(4):479-86. PubMed ID: 17694389
    [Abstract] [Full Text] [Related]

  • 15. Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia.
    Connell K, Bolton N, Olsen D, Piomelli D, Hohmann AG.
    Neurosci Lett; 2006 Apr 24; 397(3):180-4. PubMed ID: 16378681
    [Abstract] [Full Text] [Related]

  • 16. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats.
    Baranowska-Kuczko M, Kozłowska H, Kloza M, Karpińska O, Toczek M, Harasim E, Kasacka I, Malinowska B.
    Life Sci; 2016 Apr 15; 151():288-299. PubMed ID: 26969765
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.
    Seillier A, Advani T, Cassano T, Hensler JG, Giuffrida A.
    Int J Neuropsychopharmacol; 2010 Apr 15; 13(3):373-86. PubMed ID: 19607756
    [Abstract] [Full Text] [Related]

  • 18. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
    Viana TG, Hott SC, Resstel LB, Aguiar DC, Moreira FA.
    Psychopharmacology (Berl); 2015 May 15; 232(9):1545-53. PubMed ID: 25388290
    [Abstract] [Full Text] [Related]

  • 19. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
    Nucci C, Gasperi V, Tartaglione R, Cerulli A, Terrinoni A, Bari M, De Simone C, Agrò AF, Morrone LA, Corasaniti MT, Bagetta G, Maccarrone M.
    Invest Ophthalmol Vis Sci; 2007 Jul 15; 48(7):2997-3004. PubMed ID: 17591864
    [Abstract] [Full Text] [Related]

  • 20. Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo.
    Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL, Pistis M.
    Psychopharmacology (Berl); 2005 Dec 15; 183(3):368-77. PubMed ID: 16228194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.